Sider

torsdag den 18. januar 2018

D2HGDH, PHYKPL and ME

The gene D2HGDH is hypomethylated in ME patients, and this is associated with quality of life (1). Hypomethylation can result in upregulation of gene transcription. In agreement with this, gene expression of D2HGDH was upregulated in whole blood from adolescent ME/CFS patients (2).

D2HGDH encodes D-2-hydroxy-glutarate dehydrogenase, which converts D-2-hydroxyglutarate to alpha-ketoglutarate (alpha - KG). Mutations in D2HGDH are present in D-2-hydroxyglutaric aciduria, a rare neurometabolic disorder.

It is possible that 2-hydroxy glutarate is generated in relation to lysine breakdown. PHYKPL, 5-phosphohydroxy-L-lysine phospholyase, gene expression is upregulated in ME/CFS patients (2).

D2HGDH regulates alpha-KG levels and alpha-KG dependent dioxygenase function by modulating isocitrate dehydrogenase 2 (IDH2) (3).

Some of the enzymes that regulate histone and DNA methylation belong to the family of alpha-KG dependent dioxygenases.

Fx, D2HGHD induces demethylation of histone H3K4me3, so it becomes H3K4. This change is relevant to B cell differentiation (3,4)

D2HGDH is one of the genes that when mutant may promote epigenetic changes in B-cell cancer (3).

Furthermore, alpha-KG metabolism and IDH2 expression are part of the metabolic reprogramming-response in pyruvate dehydrogenase deficient cells (5).

References:

  1. Vega et al: Epigenetic modifications and glucocorticoid sensitivity in ME/CFS. BMC Medical Genomics, 2017, 10, 11
  2. Nguyen et al: Whole blood gene expression in adolescent CFS: an exploratory crosssectional study suggesting altered B cell differentiation and survival. J Transl Med. 2017,15,102.
  3. Lin et al: D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2. Nat Comm. 16.jul 2015.
  4. Barneda-Zahonero et al: Epigenetic regulation of B lymphocyte differentiation, transdifferentiation and reprogramming. Hindawi, 2012, ID564381
  5. Rajagopalan et al. Metabolic plasticity maintains proliferation in pyruvate dehydrogenase deficient cells. Cancer & Metabolism (2015) 3:7

søndag den 7. januar 2018

DGKZ and ME

ME patients have two hypermeyhylated sites in the gene DGKZ. They are associated with quality of life (1). Hypermethylation can result in suppressed transcription of the gene.

The enzyme diacylglycerol kinase zeta (DGKZ) catalyzes diacylglycerol (DAG) to phosphatidic acid (PA).

DGKZ controls DAG metabolism at the immonological synapse between the T cell and a target cell.

Disruption of DAG metabolism impairs the induction of T cell anergy, which is a process important to maintain peripheral T cell totelance.

DGKZ deficiency is associated with enhanced T cell response (2).

References:

  1. Vega et al: Epigenetic modifications and glucocorticoid sensitivity in ME/CFS. BMC Medical Genomics, 2017, 10, 11
  2. Gharbi et al: DGKZ controls diacylglycerol metabolism at the immunological synapse. Mol Biol Cell, 2011, 22, 15.

lørdag den 6. januar 2018

ATP6V0E2, PRF1, GNLY and ME

The T-cell forms an immunological synapse with a target cell. Then vesicles containing perforin and cytotoxic enzymes are released to kill the target cell. Perforin forms small pores in the membrane of the target cell. The cytotoxic vesicles are acidic (pH 5,1 - 5,4), which prevents perforin activation. Activation of perforin requires a neutral pH environment (1).

Hypermethylated genes nr. 2 and nr. 3 associated with quality of life in ME patients are ATP6V0E2 and ATP6V0E2 antisense RNA1 (2).

The gene ATP6V0E2 encodes a component of vacuolar ATPase which mediates acidification of several intracellular compartments and secretory granules/vesicles. The v-ATPase is also called proton pump or H+- ATPase.

ATP6V0E2 is an isoform of the V0e subunit. Diverse physiological functions of the v-ATPase in different membranes are established through the utilization of specific subunit isoforms.

The genes PRF1 (perforin 1) and GNLY (granulysin) are hypermethylated and associated with quality of life in ME patients (2).

Granulysin is also present in the cytotoxic vesicles of T-cells. It has antimicrobial activity.

Is the hypermethylated ATP6V0E2 related to a "pH-situation" in the cytotoxic vesicles and/or in the immunological synapse?

References:

  1. Kloc et al: The newly found functions of MTOC in immunological response. J Leucocyte Biology, 2014, 95.
  2. Vega et al: Epigenetic modifications and glucocorticoid sensitivity in ME/CFS. BMC Medical Genomics, 2017, 10, 11

tirsdag den 2. januar 2018

ACVR1, activiner og ME

Activiner er vækst og differentiations faktorer, der tilhører TGF-beta superfamilien. Activiner signalerer gennem et receptor kompleks bestående af flere forskellige receptorer. Én af disse er activin A receptor type 1 (ACVR1).

Genet for ACVR1 er hypermethyleret to forskellige steder hos ME patienter. ACVR1 optræder derfor både på 11. og 12. pladsen over epigenetiske ændrede gener, der relaterer til ME patienters livskvalitet (1).

Forhøjede niveauer af activin A og B kan påvises ved inflammatorisk respons. Hos ME patienter har man fundet:
  • normalt niveau af activin A
  • forhøjet niveau af activin B
  • lavere niveau af det activin-bindende protein follistatin (FST)
  • forhøjet ratio af activin A/FST
  • forhøjet ratio af activin B/FST
  • forhøjet ratio af activin B/activin A
Proteinet STAR transporterer kolesterol fra den ydre til den indre mitokondrie membran. Herved kan kolesterol omdannes til pregnenolone, som anvendes til videre steroid produktion.

Activin A, B og AB nedregulerer STAR expression og progesterone produktion i granulosa celler i æggestokkene (3).

Kan den generelle STAR ekspression og kolesterolomsætning være påvirket af activin / follistatinaksen hos ME patienter?

Referencer:

  1. Vega et al: Epigenetic modifications and glucocorticoid sensitivity in ME/CFS. BMC Medical Genomics, 2017, 10, 11
  2. Lidbury et al: Activin B is a novel biomarker for CFS/ME. J. Transl. Med. 2017, 15, 60.
  3. Chang et al. PMID26001835

søndag den 31. december 2017

F2 og F2R

Komplement og koagulations kaskaden bliver aktiveret ved et inflammatorisk respons. Dette afspejles i proteom studiet af cerebrospinalvæske fra ME patienter. Thrombin er en del af dette respons. Studiet viste, at fragment af prothrombin precusor (F2) var forhøjet. Værdi for ME patienter: 126, normal værdi: 27. (1)

Genet for koagulations faktor II trombin receptor (F2R) er fundet hypomethyleret hos ME patienter. Det er gen nr. 9 på listen over epigenetisk ændrede gener, der relaterer til ME patienters livskvalitet (2).

Alfa-2-macroglobulin (se sidste blogindlæg) fungerer inhibitorisk i koagulationsprocessen.

Er der noget her der hænger sammen?

Referencer:

  1. Schutzer et al: Distinct Cerebrospinal Fluid Proteomes Differentiate Post- Treatment Lyme Disease from Chronic Fatigue Syndrome. PLOS One February 2011, volume 6, Issue
  2. Vega et al: Epigenetic modifications and glucocorticoid sensitivity in ME/CFS. BMC Medical Genomics, 2017, 10, 11

lørdag den 30. december 2017

alfa-2-macroglobulin og anti-sense RNA

de Vega et al fandt 12.608 forskelligt methylerede steder i generne hos ME patienter i forhold til raske kontrolpersoner. Da disse ændringer blev relateret til ME patienternes livskvalitet kom genet for alfa-2-macroglobulin anti-sense RNA 1 ud som nr. 5-hypermethyleret (tabel S7 i ref 1).

Anti-sense RNA er komplementær til mRNA med det formål at inhibere translationen af mRNA. Dvs hvis et anti-sense gen bliver nedreguleret ved en hypermethylering, så er der ikke noget til at inhibere translationen af mRNA. Så resultatet må formodes at være rigelige mæmgder af alfa-2-macroglobulin.

To uafhægige proteomstudier på spinalvæske fra ME patienter har påvist opregulerede niveauer af alfa-2-macroglobulin (2,3).

Referencer:

  1. Vega et al: Epigenetic modifications and glucocorticoid sensitivity in ME/CFS. BMC Medical Genomics, 2017, 10, 11
  2. Schutzer et al: Distinct Cerebrospinal Fluid Proteomes Differentiate Post- Treatment Lyme Disease from Chronic Fatigue Syndrome. PLOS One February 2011, volume 6, Issue
  3. Baraniuk et al: CFS-related proteome in human CSF. BMC Neurology 2005, 5, 22.

fredag den 29. december 2017

Liver metabolism, GRAMD1A and ME

Germain et al found disturbances in fatty acid and lipid metablism in ME patients. The results were suggestive to damage to liver / a deficiency in liver activity (1).

de Vega et al showed that the most hypermethylated gene associated with quality of life in ME patients was GRAMD1A. A hypermethylated gene is often associated with supressed transcription (2).

GRAMD1A promotes the expansion of hepatocellular carcinoma stem cell and hepatocellular carcinoma growth through STAT5 (3).

If up-regulated GRAMD1A up-regulates STAT5 and induces growth in cancer cells, what do a down-regulated GRAMD1A do in ME patients? In liver cells? In lymphocytes?

STAT5 is involved in lymphocyte development and transformation. And STAT5 promotes the proliferation, survival and selfrenewal of hematopoietic stem cells (ref 21-24 in ref 3).

References:

  1. Germain et al: Metabolic profiling of a ME/CFS discovery cohort reveals disturbances in fatty acid and lipid metabolism. Mol. BioSyst. 2017, 13, 371
  2. Vega et al: Epigenetic modifications and glucocorticoid sensitivity in ME/CFS. BMC Medical Genomics, 2017, 10, 11
  3. Binsheng Fu et al: GRAMD1A promotes the expansion of hepatocellular carcinoma stem cell and hepatocellular carcinoma growth through STAT5. Nature Scientific Reports, 2. sept 2016.